NCT07456852 2026-03-09
Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy
Mayo Clinic
Phase 1/2 Not yet recruiting
Mayo Clinic
Luye Pharma Group Ltd.
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Fudan University
Tianjin Medical University Cancer Institute and Hospital